Effects of SiO2, ZrO2, and BaSO4 nanomaterials with or without surface functionalization upon 28-day oral exposure to rats

Archives of Toxicology

Volumn 88, Issue 10, 2014, Pages 1881-1906

  Buesen, Roland ^a   Landsiedel, Robert ^a   Sauer, Ursula G ^b   Wohlleben, Wendel ^a   Groeters, Sibylle ^a   Strauss, Volker ^a   Kamp, Hennicke ^a   van Ravenzwaay, Bennard ^a  

^a BASF SE   (Germany)

^b Animal Welfare Academy   (Germany)

Author keywords

Metabolomics; Nanomaterial (NM); OECD test guideline 407; Oral route of exposure; Subacute toxicity; Surface functionalization

Indexed keywords

ALPHA 2 MACROGLOBULIN; BARIUM SULFATE NANOPARTICLE; HAPTOGLOBIN; NANOPARTICLE; SILICA NANOPARTICLE; TROPONIN I; UNCLASSIFIED DRUG; ZIRCONIUM DIOXIDE NANOPARTICLE; BARIUM SULFATE; NANOMATERIAL; SILICON DIOXIDE; ZIRCONIUM; ZIRCONIUM OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BODY BURDEN; CONTROLLED STUDY; EXPOSURE; FEMALE; INHALATION; MALE; METABOLOME; METABOLOMICS; NANOTOXICOLOGY; NONHUMAN; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; SURFACE PROPERTY; TOXICITY TESTING; ANIMAL; CHEMISTRY; ORAL DRUG ADMINISTRATION; WISTAR RAT;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BARIUM SULFATE; FEMALE; MALE; NANOSTRUCTURES; RATS, WISTAR; SILICON DIOXIDE; SURFACE PROPERTIES; TOXICITY TESTS, SUBCHRONIC; ZIRCONIUM;

EID: 84919905019     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1337-0     Document Type: Article

References (75)

1. 4: a novel antimicrobial additive to pellethane. Int J Nanomed 8:1197–1205
2. Anon (2006) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396:1, 30 December 2006
3. Anon (2012) Commission staff working paper accompanying the Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee on the second regulatory review on nanomaterials: Types and uses of nanomaterials, including safety aspects (COM(2012) 572 final. SWD(2012) 288 final. Brussels, 3 October 2012
4. Bouwmeester H, Poortman J, Peters RJ, Wijma E, Kramer E, Makama S, Puspitaninganindita S, Marvin HJP, Peijnenburg AACM, Hendriksen PJM (2011) Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 5:4091–4103
5. Bu Q, Yan G, Deng P, Peng F, Lin H, Xu Y, Cao Z, Zhou T, Xue A, Wang Y, Cen X, Zhao YL (2010) NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnol 21:125105
6. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH (2013) Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:9
7. Coco R, Plapied L, Pourcelle V, Jérôme C, Brayden DJ, Schneider YJ, Préat V (2013) Drug delivery to inflamed colon by nanoparticles: comparison of different strategies. Int J Pharm 440:3–12
8. Dekkers S, Bouwmeester H, Bos PMJ, Peters RJB, Rietveld AG, Oomen AG (2013) Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica. Nanotoxicol 7(4):367–377
9. Delie F (1998) Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv Drug Deliv Rev 34:221–233
10. ECETOC (2002) Recognition of, and differentiation between, adverse and non-adverse effects in toxicology studies. Technical Report No. 85. ISSN-0773-6347-85, Brussels, December 2002
11. ECETOC (2008) WR 11. Workshop on the application of ‘omics’ in toxicology and ecotoxicology: case studies and risk assessment. Brussels, July 2008. http://www.ecetoc.org/workshop-reports
12. ECETOC (2010) WR 19. Omics in (eco)toxicology: case studies and risk assessment. June 2010. http://www.ecetoc.org/workshop-reports
13. ECETOC (2013) WR 25. ‘Omics and risk assessment science. October 2013. http://www.ecetoc.org/workshop-reports
14. ECHA (2012) Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific guidance. European Chemicals Agency ECHA-12-G-03-EN, April 2012. 60 pp. http://echa.europa.eu/documents/10162/13632/appendix_r7a_nanomaterials_en.pdf
15. EFSA (2009) Scientific opinion on the potential risks arising from nanoscience and nanotechnologies on food and feed safety. Response to question EFSA-Q-2007-124a. 10 February 2009. EFSA J 958:1–39. http://www.efsa.europa.eu/en/efsajournal/doc/1052.pdf
16. EFSA (2011) Scientific opinion: guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. 10 May 2011. EFSA J 9:2140. http://www.efsa.europa.eu/de/efsajournal/pub/2140.htm
17. Fallingborg J (1999) Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 46:183–196
18. Feng J, Liu H, Zhang L, Bhakoo K, Lu L (2010) An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids. Nanotechnol 21:395101
19. Florence AT (1997) The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceut Res 14:259–266
20. Florence AT (2005) Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discovery Today: Technol 2:75–81
21. Fröhlich E, Roblegg E (2012) Models for oral uptake of nanoparticles in consumer products. Toxicol 291:10–17
22. Gad SC, Cassidy CD, Aubert N, Spainhour B, Robbe H (2006) Nonclinical vehicle use in studies by multiple routes in multiple species. Int J Toxicol 25:499–521
23. Hadrup N, Lam HR (2014) Oral toxicity of silver ions, silver nanoparticles and colloidal silver—a review. Regul Toxicol Pharmacol 68:1–7
24. Hadrup N, Loeschner K, Bergström A, Wilcks A, Gao X, Vogel U, Frandsen HL, Larsen EH, Lam HR, Mortensen A (2012a) Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch Toxicol 86:543–551
25. Hadrup N, Lam HR, Loeschner K, Mortensen A, Larsen EH, Frandsen H (2012b) Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics. J Appl Toxicol 32:929–933
26. Hankin SM, Peters SAK, Poland CA, Foss Hansen S, Holmqvist J, Ross BL, Varet J, Aitken RJ (2011) Specific advice on fulfilling information requirements for nanomaterials under REACH (RIP-oN 2)—final project peport. REACH-NANO consultation. RNC/RIP-oN2/FPR/1/FINAL. 356 pp. http://ec.europa.eu/environment/chemicals/nanotech/pdf/report_ripon2.pdf
27. Higashisaka K, Yoshioka Y, Yamashita K, Morishita Y, Fujimura M, Nabeshi H, Nagano K, Abe Y, Kamada H, Tsunoda S, Yoshikawa T, Itoh N, Tsutsumi Y (2011) Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomat 32:3–9
28. Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–1936
29. Hong JS, Kim S, Lee SH, Jo E, Lee B, Yoon J, Eom IC, Kim HM, Kim P, Choi K, Lee MY, Seo YR, Kim Y, Lee Y, Choi J, Park K (2014) Combined repeated-dose toxicity study of silver nanoparticles with the reproduction/developmental toxicity screening test. Nanotoxicol 8:349–362
30. 2 nanoparticles in MRC-5 human fetal lung fibroblasts. Adv Health Mater 1:779–784
31. Kamp H, Buesen R, Fabian E, Herold M, Krennrich G, Leibold E, Looser R, Mellert W, Nishino T, Prokoudine A, Strauss V, Walk T, Wiemer J, van Ravenzwaay B (2010) Metabolite profiling in rat plasma as a potential new tool for the assessment of chemically induced toxicity. In: DFG. Risk Assessment of Phytochemicals in Food. Wiley, Weinheim, ISBN 978-3-527-32929-8
32. Kamp H, Strauss V, Wiemer J, Leibold E, Walk T, Mellert W, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B (2012a) Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. Toxicol Lett 215:143–149
33. Kamp H, Fabian E, Groeters S, Herold M, Krennrich G, Looser R, Mattes W, Mellert W, Prokoudine A, Ruiz-Noppinger P, Strauss V, Walk T, Wiemer J, van Ravenzwaay B (2012b) Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity. Bioanalysis 4:2291–2301
34. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ (2008) Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575–583
35. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ (2010) Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20
36. Kuhlbusch TA, Krug HF, Nau K (eds) (2009) Nanocare—health related effects of nanoparticles. Final scientific report. Frankfurt, Dechema eV
37. Kumari M, Rajak S, Singh SP, Kumari SI, Kumar PU, Murty USN, Mahboob M, Grover P, Rahman MF (2012) Repeated oral dose toxicity of iron oxide nanoparticles: biochemical and histopathological alterations in different tissues of rats. J Nanosci Nanotechnol 12:2149–2159
38. Lai DY (2012) Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:1–15
39. Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K (2012a) Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:399–413
40. Landsiedel R, Fabian E, Ma-Hock L, Wohlleben W, Wiench K, Oesch F, van Ravenzwaay B (2012b) Toxico-/biokinetics of nanomaterials. Arch Toxicol 86:1021–1060
41. Landsiedel R, Ma-Hock L, Hofmann T, Wiemann M, Strauss V, Treumann S, Wohlleben W, Gröters S, Wiench K, van Ravenzwaay B (2014) Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part Fibre Toxicol 11:16
42. Liao MY, Liu HG (2012) Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Env Toxicol Pharmacol 34:67–80
43. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH (2011) Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18
44. Lu X, Tian Y, Zhao Q, Jin T, Xiao S, Fan X (2011) Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnol 22:055101
45. Matsumoto M, Serizawa H, Sunaga M, Kato H, Takahashi M, Hirata-Koizumi M, Ono A, Kamata E, Hirose A (2012) No toxicological effects on acute and repeated oral gavage doses of single-wall or multi-wall carbon nanotubes in rats. J Toxicol Sci 37:463–474
46. Nagano T, Yoshioka Y, Higashisaka K, Kunieda A, Hata K, Nagano K, Abe Y, Kamada H, Tsunoda S, Nabeshi H, Yoshikawa T, Tsutsumi Y (2012) Potential of acute-phase proteins as biomarkers for sub-nano platinum exposure. Pharmazie 67:958–959
47. st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607–621
48. OECD (2008a) List of manufactured nanomaterials and list of endpoints for phase one of the OECD testing programme. Series on the safety of manufactured nanomaterials, number 6. ENV/JM/MONO(2008)13/REV, OECD, Paris, 7 July 2008
49. OECD (2008b) Repeated-dose 28-day oral toxicity study in rodents. OECD guidelines for the testing of chemicals No. 407. OECD, Paris, 3 October 2008
50. OECD (2010) Guidance manual for the testing of manufactured nanomaterials: OECD’s sponsorship programme; first revision. ENV-JM-MONO(2009)20-REV, OECD, Paris, 2 June 2010
51. Oomen AG, Bos PMJ, Fernandes TF, Hund-Rinke K, Boraschi D, Byrne HJ, Aschberger K, Gottardo S, van der Kammer F, Kühnel D, Hristozov D, Marcomini A, Migliore L, Scott-Fordsmand J, Wick P, Landsiedel R (2014) Concern-driven integrated approaches to nanomaterial testing and assessment—Report of the NanoSafety Cluster Working Group 10. Nanotoxicol 8:334–348
52. Park E-J, Bae E, Yi J, Kim Y, Choi K, Lee SH, Yoon J, Lee BC, Park K (2010) Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Env Toxicol Pharmacol 30:162–168
53. Parveen A, Rizvi SH, Gupta A, Singh R, Ahmad I, Mahdi F, Mahdi AA (2012) NMR-based metabonomics study of sub-acute hepatotoxicity induced by silica nanoparticles in rats after intranasal exposure. Cell Mol Biol 58(1):196–203
54. 4 particle size additives on properties of PMMA bone cement. Int J Nanomed 3(1):125–132
55. RIP-oN 1 (2011) REACH implementation project. Substance identification of nanomaterials. Advisory Report. AA N° 070307/2009/DI/534733 between DG ENV and JRC. European Commission, Joint Research Centre, Institute for Health and Consumer Protection. 76 pp. http://ec.europa.eu/environment/chemicals/nanotech/pdf/report_ripon1.pdf
56. Savolainen K, Backman U, Brouwer D, Fadeel B, Fernandes T, Kuhlbusch T, Landsiedel R, Lynch I, Pylkkänen L (2013) Nanosafety in Europe 2015–20125: towards safe and sustainable nanomaterials and nanotechnology innovations. Finnish Institute of Occupational Health, Finland. 218 pp. www.ttl.fi/en/publications/electronic_publications/pages/default.aspx
57. Schnackenberg LK, Sun J, Beger RD (2012) Metabolomics techniques in nanotoxicology studies. Methods Mol Biol 926:141–156
58. Seok SH, Cho W-S, Park JS, Na Y, Jang A, Kim H, Cho Y, Kim T, You J-R, Ko S, Kang B-C, Lee JK, Jeong J, Che J-H (2013) Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. J Appl Toxicol 33:1089–1096
59. Shakibaie M, Shahverdi AR, Faramarzi MA, Hassanzadeh GR, Rahimi HR, Sabzevari O (2013) Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharmaceut Biol 51:58–63
60. Sharma V, Singh P, Pandey AK, Dhawan A (2012) Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res 745:84–91
61. Singh SP, Kumari M, Kumari SI, Rahman MF, Mahboob M, Grover P (2013) Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure. J Appl Toxicol 33:1165–1179
62. Hellak B, Hülser T, Izak E, Kuhlbusch T, Meyer F, Spree, M, Voetz M, Wiggers H, Wohlleben W (2012) NanoGEM deliverable 1.3.1: Characterization report for all nanoGEM materials. M24, 41 pp. http://www.nanogem.de/cms/nanogem/upload/Veroeffentlichungen/nanoGEM_Del1.3.1_Characterization_Materials_2013_04_24.pdf
63. Takahashi M, Kato H, Doi Y, Hagiwara A, Hirata-Koizumi M, Ono A, Kubota R, Nishimura T, Hirose A (2012) Sub-acute oral toxicity study with fullerene C60 in rats. J Toxicol Sci 37:353–361
64. Tang M, Zhang T, Xue Y, Wang S, Huang M, Yang Y, Lu M, Lei H, Kong L, Yuepu P (2010) Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. J Nanosci Nanotechnol 10:8575–8583
65. Tassinari R, Cubadda F, Moracci G, Aureli F, D’Amato M, Valeri M, De Berardis B, Raggi A, Mantovani A, Passeri D, Rossi M, Maranghi F (2014) Oral, short-term exposure to titanium dioxide nanoparticles in Sprague–Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicol 8:654–662
66. van der Zande M, Vandebriel RJ, van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJB, Hollman PCH, Hendriksen PJM, Marvin HJP, Peijnenburg AACM, Bouwmeester H (2012) Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427–7442
67. van der Zande M, Vandebriel RJ, Groot MJ, Kramer E, Rivera ZH, Rasmussen K, Ossenkoppele JS, Tromp P, Gremmer ER, Peters RJB, Hendriksen PJ, Marvin HJP, Peijnenburg AACM, Bouwmeester H (2014) Sub-chronic toxicity study in rats orally exposed to nanostructured silica. Part Fibre Toxicol 11:8
68. van Ravenzwaay B, Cunha GC-P, Leibold E, Looser R, Mellert W, Prokoudine A, Walk T, Wiemer J (2007) The use of metabolomics for the discovery of new biomarkers of effect. Toxicology Lett 172:21–28
69. van Ravenzwaay B, Coelho-Palermo Cunha G, Fabian E, Herold M, Kamp H, Krennrich G, Krotzky A, Leibold E, Looser R, Mellert W, Prokoudine A, Strauss V, Trethewey R, Walk T, Wiemer J (2010a) The use of metabolomics in cancer research. In: Cho WCS (ed) An omics perspective of cancer. Springer, Berlin, pp 141–166
70. van Ravenzwaay B, Coelho-Palermo Cunha G, Strauss V, Wiemer J, Leibold E, Kamp H, Walk T, Mellert W, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M (2010b) The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats. Toxicology Lett 198:159–170
71. van Ravenzwaay B, Herold M, Kamp H, Kapp MD, Fabian E, Looser R, Krennrich G, Mellert W, Prokoudine A, Strauss V, Walk T, Wiemer J (2012a) Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. Mutat Res 746:144–150
72. van Ravenzwaay B, Brunborg G, Kleinjans J, Galay Burgos M, Vrijhof H (2012b) Use of ‘omics to elucidate mechanism of action and integration of ‘omics in a systems biology concept. Mutat Res 746:95–96
73. Wohlleben W (2012) Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J Nanopart Res 14:1300
74. Wohlleben W, Ma-Hock L, Boyko V, Cox G, Egenolf H, Freiberger H, Hinrichsen B, Hirth S, Landsiedel R (2013) Nanospecific guidance in REACH: a comparative physicalchemical characterization of 15 materials with methodical correlations. J Ceramic Sci Technol 4:93–104
75. Wohlleben W, Kuhlbusch T, Lehr CM, Schnekenburger J (eds) (2014) Safety of nanomaterials along their lifecycle: release, exposure and human hazards. Taylor & Francis Oxford, New York, ISBN 978-1-46-656786-3, (in print)